TNFRSF10B and neoplasm: Among different tumor-associated antigens (TAA), we have previously demonstrated that the death receptor TNF-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) could be used to efficiently retarget T cells and use their cytotoxic armamentarium against tumors [5].